Can an esmolol infusion cause confusion, and should the infusion be stopped or its rate reduced?

Can Esmolol Infusion Cause Confusion?

Yes, esmolol infusion can cause confusion, primarily through hypotension-induced cerebral hypoperfusion, and the infusion should be reduced or stopped if confusion develops, particularly when accompanied by hemodynamic instability.

Mechanism and Clinical Context

Esmolol itself does not directly cause CNS depression or confusion as a primary pharmacologic effect. The FDA label 1 does not list confusion as a direct adverse effect. However, confusion can occur as a secondary consequence of esmolol's cardiovascular effects, particularly:

• Hypotension: The most common adverse effect (incidence 0-50% depending on dose), which can reduce cerebral perfusion 1, 2
• Bradycardia: Can compromise cardiac output and cerebral blood flow 1
• Reduced cardiac output: Beta-blockade decreases myocardial contractility 1

Critical Consideration: Formulation-Related Hyponatremia

A critical but often overlooked cause of confusion with esmolol is acute hyponatremia from the sterile water formulation. A 2024 case report 3 documented a patient who developed seizures and a 14 mEq/L drop in serum sodium after receiving >6L of esmolol formulated in sterile water over 2 days. The confusion and seizures resolved after discontinuing esmolol and correcting the sodium. Always check which esmolol formulation is being used and monitor serum sodium, especially with prolonged or high-volume infusions.

When to Reduce or Stop Esmolol

Reduce the infusion rate or stop esmolol if:

1. Confusion develops with hypotension (systolic BP <90-100 mmHg or >25% drop from baseline)
2. Confusion develops with bradycardia (HR <50 bpm or symptomatic)
3. Serum sodium drops acutely (check if using sterile water formulation)
4. Signs of cerebral hypoperfusion appear (altered mental status, dizziness, syncope)

The FDA label 1 explicitly states: "In case of an unacceptable drop in blood pressure, reduce or stop esmolol hydrochloride. Decrease of dose or termination of infusion reverses hypotension, usually within 30 minutes."

Practical Management Algorithm

If confusion develops during esmolol infusion:

1. Immediately assess hemodynamics: Check BP, HR, and cardiac output parameters
2. Check serum sodium: Especially if using sterile water formulation or high-volume/prolonged infusion
3. If hypotensive (SBP <90 mmHg or symptomatic):
   • Stop or reduce esmolol infusion immediately
   • Hypotension typically resolves within 30 minutes of stopping 1, 2
   • Consider vasopressor support if needed
4. If bradycardic (HR <50 bpm or symptomatic):
   • Reduce or stop esmolol
   • Bradycardia resolves rapidly given 9-minute elimination half-life 2
5. If hyponatremic:
   • Stop esmolol in sterile water formulation
   • Switch to alternative antihypertensive
   • Initiate appropriate sodium correction 3

Dosing Considerations to Minimize Risk

The ACC/AHA guidelines 4, 5 recommend esmolol dosing of 500-1000 mcg/kg loading dose over 1 minute, followed by 50 mcg/kg/min infusion, with incremental increases up to maximum 200 mcg/kg/min. Hypotension risk increases significantly at doses >150 mcg/kg/min 2.

For patients at higher risk (elderly, low baseline BP, heart failure), consider:

• Starting at lower maintenance doses (50 mcg/kg/min)
• Slower titration
• More frequent hemodynamic monitoring
• Avoiding the sterile water formulation if prolonged use anticipated

Key Advantages of Esmolol in This Context

The ultra-short half-life (9 minutes) 1, 2 makes esmolol particularly safe when confusion develops, as adverse effects resolve within 18-30 minutes of stopping the infusion 2. This rapid reversibility is a major advantage over longer-acting beta-blockers when neurological symptoms emerge.

Common Pitfalls

• Failing to recognize formulation-related hyponatremia as a cause of confusion with esmolol
• Not monitoring BP closely enough, especially at doses >150 mcg/kg/min
• Attributing confusion to other causes without considering esmolol-induced hypotension
• Using excessive doses in elderly or hemodynamically compromised patients
• Not recognizing that confusion will resolve rapidly once esmolol is stopped or reduced